Bringing you the latest financial results from Bruker Corporation. In the second quarter of 2025, the company reported revenues of $797.4 million, marking a slight decrease of 0.4% compared to the same period in 2024. However, organic revenue took a hit, declining by 7.0% year-over-year (YoY), with constant-exchange rate (CER) revenue also down by 3.3% YoY.
The second quarter of 2025 saw Bruker Scientific Instruments (BSI) revenues at $733.2 million, a decrease of 0.3% YoY, with organic revenue down by 7.2% YoY. On the other hand, Bruker Energy & Supercon Technologies (BEST) revenues were at $66.3 million, down by 4.1% YoY, with organic revenue, net of intercompany eliminations, decreasing by 4.8% YoY.
Moving on to the financial performance, the GAAP operating income for the second quarter of 2025 was $11.9 million, significantly lower than the $48.1 million reported in the second quarter of 2024. The non-GAAP operating income for the same period was $72.0 million, down from $110.7 million in the second quarter of 2024. Additionally, the non-GAAP operating margin was 9.0%, a decline from 13.8% in the second quarter of 2024.
In terms of earnings per share (EPS), the second quarter of 2025 saw GAAP diluted EPS at $0.05, remaining flat from the second quarter of 2024. However, non-GAAP diluted EPS experienced a significant decrease of 38.5%, coming in at $0.32 compared to $0.52 in the second quarter of 2024.
Looking at the first half of 2025, Bruker's revenues were $1.60 billion, reflecting a 5.0% increase from the first half of 2024. However, organically, revenues decreased by 2.3% YoY, with CER YoY growth of 4.2%. The BSI revenues for the first half of 2025 were $1.48 billion, showing a 6.6% increase from the first half of 2024, while BEST revenues of $125.6 million decreased by 11.7% YoY.
In the first half of 2025, the GAAP operating income was $43.7 million, a decline from $112.9 million in the first half of 2024. The non-GAAP operating income for the same period was $173.7 million, down 17.8% from the first half of 2024. The non-GAAP operating margin was 10.9%, compared to 13.9% in the first half of 2024. Additionally, the GAAP diluted EPS for the first half of 2025 was $0.16, down from $0.40 in the first half of 2024, while the non-GAAP diluted EPS was $0.78, a decrease of 25.7% from $1.05 in the first half of 2024.
Furthermore, Bruker has updated its fiscal year 2025 financial outlook, now expecting revenues of $3.43 to $3.50 billion, compared to $3.37 billion in fiscal year 2024. The company anticipates non-GAAP EPS of $1.95 to $2.05, down from $2.41 in fiscal year 2024.
In response to the current market conditions, Bruker is initiating a cost savings initiative expected to reduce annual costs by $100 * $120 million in fiscal year 2026. This move is aimed at supporting the company's commitment to resume rapid margin expansion and double-digit EPS growth next year, even in a scenario where demand remains muted.
For those interested in diving deeper into these results and gaining insights into Bruker's business outlook, the company will be hosting a conference call and webcast to discuss its financial results, business outlook, and related corporate and financial matters on August 4, 2025, at 8:30 am Eastern Daylight Time. The market has reacted to these announcements by moving the company's shares -7.45% to a price of $35.16. If you want to know more, read the company's complete 8-K report here.
